Delivery Order SPE2DB22D3401-SPE2DB25FT2ZQ

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,630.20 and an ultimate completion date of January 30, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The delivery order is valued at $2,188.87 and has a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naloxone HCl 4 mg nasal spray, a critical medication used to reverse opioid overdose. The contract has a ceiling value of $3,313.76 and will run through January 29, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a firm fixed price of $1,342.48 and a period of performance through March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The contract has a firm fixed price ceiling of $4,428.73 and a completion date of September 20, 2023. It is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,354.77, is for the delivery of 4 mg Naloxone HCl Nasal Spray, a critical medication used to treat opioid overdoses. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 2, 2025. The contract has no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used for the treatment of opioid overdose. The Delivery Order has a Firm Fixed Price of $2,926.80 and a completion date of February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,287.20 and a completion date of February 25, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,549,272 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a total ceiling value of $3,275.59 and a completion date of October 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2ZQ
    Delivery Order

This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used to reverse opioid overdoses. The total ceiling value of the contract is $1,315.00, with an ultimate completion date of April 2, 2025. This contract award is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for supplying this essential medical product to support federal healthcare programs, particularly within the military and veterans' healthcare systems. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense.

Generated 7/1/25, 9:17 AM